The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic
Background: Patients with inflammatory bowel disease (IBD) often require the use of immunosuppressant medications that increase infection risk, leading to concerns over the safe use of IBD medications during the Coronavirus 19 (COVID-19) pandemic. Objectives: To summarize available evidence on the s...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | Current Research in Pharmacology and Drug Discovery |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257122000219 |